Pluribus Labs’s Hess HES Stock Holding History

Pluribus Labs’s Portfolio HES Stock Details HES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,643	Closed	-$270K	–	141
2021 Q4	$270K	Buy	+3,643	New	+$295K	0.28%	148

Other funds holding HES

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Pluribus Labs's HES Position: Q1 2022 in Review

Pluribus Labs sold out of Hess (HES) in Q1 2022, closing a stake of 3,643 shares — an estimated $270K sold.

Pluribus Labs first reported a position in HES in Q4 2021 and held it in 1 quarter. The position peaked at $270K in Q4 2021. 640 funds tracked by Wall St. Rank hold HES as of Q1 2022.

Pluribus Labs reported no remaining Hess position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 3,643 Hess shares in Q1 2022, an estimated $270K.
Pluribus Labs first reported a position in Hess in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Hess position peaked at $270K in Q4 2021.
640 funds tracked by Wall St. Rank held Hess as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.